BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32524436)

  • 1. Radiomic features of Pk-DCE MRI parameters based on the extensive Tofts model in application of breast cancer.
    Zhou X; Gao F; Duan S; Zhang L; Liu Y; Zhou J; Bai G; Tao W
    Phys Eng Sci Med; 2020 Jun; 43(2):517-524. PubMed ID: 32524436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
    Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
    BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomic features of axillary lymph nodes based on pharmacokinetic modeling DCE-MRI allow preoperative diagnosis of their metastatic status in breast cancer.
    Luo HB; Liu YY; Wang CH; Qing HM; Wang M; Zhang X; Chen XY; Xu GH; Zhou P; Ren J
    PLoS One; 2021; 16(3):e0247074. PubMed ID: 33647031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DCE-MRI Pharmacokinetic-Based Phenotyping of Invasive Ductal Carcinoma: A Radiomic Study for Prediction of Histological Outcomes.
    Monti S; Aiello M; Incoronato M; Grimaldi AM; Moscarino M; Mirabelli P; Ferbo U; Cavaliere C; Salvatore M
    Contrast Media Mol Imaging; 2018; 2018():5076269. PubMed ID: 29581709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer.
    Nagasaka K; Satake H; Ishigaki S; Kawai H; Naganawa S
    Breast Cancer; 2019 Jan; 26(1):113-124. PubMed ID: 30069785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
    Kang SR; Kim HW; Kim HS
    J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomic Analysis of Pharmacokinetic Heterogeneity Within Tumor Based on the Unsupervised Decomposition of Dynamic Contrast-Enhanced MRI for Predicting Histological Characteristics of Breast Cancer.
    Zhang L; Fan M; Wang S; Xu M; Li L
    J Magn Reson Imaging; 2022 Jun; 55(6):1636-1647. PubMed ID: 34773446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
    Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
    J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-lesion histogram and texture analyses of breast lesions on inline quantitative DCE mapping with CAIPIRINHA-Dixon-TWIST-VIBE.
    Sun K; Zhu H; Chai W; Zhan Y; Nickel D; Grimm R; Fu C; Yan F
    Eur Radiol; 2020 Jan; 30(1):57-65. PubMed ID: 31372782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient estimation of pharmacokinetic parameters from breast dynamic contrast-enhanced MRI based on a convolutional neural network for predicting molecular subtypes.
    Zhang L; Fan M; Li L
    Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37983902
    [No Abstract]   [Full Text] [Related]  

  • 11. Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI.
    Liu C; Ding J; Spuhler K; Gao Y; Serrano Sosa M; Moriarty M; Hussain S; He X; Liang C; Huang C
    J Magn Reson Imaging; 2019 Jan; 49(1):131-140. PubMed ID: 30171822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomic analysis of HTR-DCE MR sequences improves diagnostic performance compared to BI-RADS analysis of breast MR lesions.
    Perre SV; Duron L; Milon A; Bekhouche A; Balvay D; Cornelis FH; Fournier L; Thomassin-Naggara I
    Eur Radiol; 2021 Jul; 31(7):4848-4859. PubMed ID: 33404696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
    Chang RF; Chen HH; Chang YC; Huang CS; Chen JH; Lo CM
    Magn Reson Imaging; 2016 Jul; 34(6):809-819. PubMed ID: 26968141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravoxel incoherent motion MR imaging for breast lesions: comparison and correlation with pharmacokinetic evaluation from dynamic contrast-enhanced MR imaging.
    Liu C; Wang K; Chan Q; Liu Z; Zhang J; He H; Zhang S; Liang C
    Eur Radiol; 2016 Nov; 26(11):3888-3898. PubMed ID: 26863896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
    Shin JK; Kim JY
    J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging.
    Cheng Z; Wu Z; Shi G; Yi Z; Xie M; Zeng W; Song C; Zheng C; Shen J
    Eur Radiol; 2018 Mar; 28(3):982-991. PubMed ID: 28929243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the clinicopathological subtypes of breast cancer using a fisher discriminant analysis model based on radiomic features of diffusion-weighted MRI.
    Ni M; Zhou X; Liu J; Yu H; Gao Y; Zhang X; Li Z
    BMC Cancer; 2020 Nov; 20(1):1073. PubMed ID: 33167903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of triple-negative breast cancer and androgen receptor expression based on histogram and texture analysis of dynamic contrast-enhanced MRI.
    Xu WJ; Zheng BJ; Lu J; Liu SY; Li HL
    BMC Med Imaging; 2023 Jun; 23(1):70. PubMed ID: 37264313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.
    Fan M; Cheng H; Zhang P; Gao X; Zhang J; Shao G; Li L
    J Magn Reson Imaging; 2018 Jul; 48(1):237-247. PubMed ID: 29219225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between the dynamic contrast-enhanced MRI features and prognostic factors in breast cancer: A retrospective case-control study.
    Tao W; Hu C; Bai G; Zhu Y; Zhu Y
    Medicine (Baltimore); 2018 Jul; 97(28):e11530. PubMed ID: 29995825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.